Fund profile / Germany

naturalX Health Ventures (I)

Geography: Germany
Stage: Seed
Fund size: €100M
Focus: Digital Health and E-Commerce
Signals: Published

N°01 / About

About naturalX Health Ventures (I)

naturalX Health Ventures (I) is a venture capital firm based in Germany, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in E-Commerce, Digital Health, providing strategic guidance and capital to help startups scale.

N°02 / Thesis

Investment Focus

Location / RegionGermany

Funding StageSeed

Industry Focus

Digital Health

E-Commerce

Investor Signals Profile

active

Sweet Spot

Clinical founder with FDA pathway, clinician-led distribution moat

consumer health

clinical-grade products

mental health

neurotech

FDA-approved devices

prescription distribution

tDCS/neurostimulation

women's health

channel acquisition

employer/pharmacy distribution

health scoring/biometrics

access barriers

language localization

care navigation

benefits consolidation

Bullish Signals

Backing clinical-grade consumer health winnersexternal

Flow Neuroscience: FDA approval + nationwide prescription accesslinkedin

3,608 LinkedIn followers, active publishinglinkedin

Wellness splitting: infrastructure vs. claim-heavy scrutinylinkedin

AI moving closer to care deliverylinkedin

Prevention & neurotech capital flows uplinkedin

Medicare coverage changes flagged as opportunitylinkedin

Employer as distribution door > DTClinkedin

Pharmacies expanding clinical scope, automation risinglinkedin

Everyday devices becoming clinical measurement toolslinkedin

Vertical consolidation of healthcare workflows winninglinkedin

Big tech/health systems shipping AI assistants at scalelinkedin

Infrastructure & data layers selling into platform ecosystemslinkedin

Legacy supplement infrastructure still has strategic appetitelinkedin

Femtech consolidating via acquisition, not new platformslinkedin

Neurotech reaching FDA + prescription milestone validates thesisexternal

Big tech integrating health scoring into default consumer productsexternal

Language/access barriers real friction points in pharmacyexternal

Care navigation & benefits consolidating into employer ecosystemsexternal

Femtech solving specific problems at small check sizesexternal

Contrarian Signals

High evidence bar may slow deal paceexternal

No GP info publicly visibleexternal

Governance complexity: reimbursement + oversight requiredlinkedin

Attention, evidence & permission all scarcerlinkedin

Channel acquisition often requires incumbent relationshipslinkedin

Standalone consumer health AI apps losing distribution warlinkedin

Big platforms building own AI layer, crowding out startupslinkedin

Health scoring metrics face trust/validation skepticism vs. big techexternal

Founder Do's

Prove clinical outcomes with evidence

Build reimbursement & clinician workflow logic

Target durable care relationships, not engagement

Integrate into clinical workflows, not alongside

Show clear safety rails & oversight

Own distribution channels, not just customers

Pursue employer/pharmacy/healthcare system partnerships first

Pursue FDA approval for genuine innovation

Build prescription-only pathway for clinical moat

Prove outcomes over years of evidence-building

Solve unglamorous access friction (language, literacy, trust)

Build products for embedded ecosystem integration, not standalone

Founder Don'ts

Loose health claims without evidence

Engagement-only tools, no clinical value

Chase DTC/consumer acquisition before channel access

Compete on unvalidated metrics vs. big tech defaults

45 signals on naturalX Health Ventures (I)

20 bullish · 8 contrarian · 12 pitch do's · 4 don'ts · 1 GP profile, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size€100M

Saves0

Website

People

Key People

Marvin Amberg

UnknownPartner

N°04 / See also

Related Funds

Auxxo Female Catalyst Fund II

Fund size€26M

Location: Germany
Stage: Seed
Focus: Saas, Enterprise Software, Climate Sustainability
Manager: Gesa Miczaika, Bettine Schmitz

Seed

Saas

Enterprise Software

Climate Sustainability

Oyster Bay Venture Capital Fund II

Fund size€100M

Location: Germany
Stage: Seed
Focus: Supply Chain, Agritech, Food Tech, Consumer Commerce, Circular Economy, Climate Sustainability

Seed

Supply Chain

Agritech

Food Tech

Consumer Commerce

Circular Economy

Climate Sustainability

DTCP European Defence VC Fund

Fund size€500M

Location: Germany
Stage: Seed
Focus: Manufacturing, Defense, Space, Cybersecurity, Ai Ml
Manager: Thomas Preuss, Philipp von Bismarck, Jack J. Young

Seed

Manufacturing

Defense

Space

Cybersecurity

Ai Ml